Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 2260

1.

[III. Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer].

Tsugawa K, Nagasawa S.

Gan To Kagaku Ryoho. 2014 Dec;41(13):2568-70. Japanese. No abstract available.

PMID:
25668825
2.

[II.clinical significance of second sentinel node biopsy in breast cancer surgery].

Iwase T.

Gan To Kagaku Ryoho. 2014 Dec;41(13):2563-7. Japanese. No abstract available.

PMID:
25668824
3.

[I.strategy of axillary management for sentinel node – positive breast cancer patients].

Imoto S.

Gan To Kagaku Ryoho. 2014 Dec;41(13):2560-2. Japanese. No abstract available.

PMID:
25668823
4.

Management of the regional lymph nodes following breast-conservation therapy for early-stage breast cancer: an evolving paradigm.

Warren LE, Punglia RS, Wong JS, Bellon JR.

Int J Radiat Oncol Biol Phys. 2014 Nov 15;90(4):772-7. doi: 10.1016/j.ijrobp.2014.07.006. Epub 2014 Oct 18. Review.

PMID:
25585780
5.

A histomorphologic predictive model for axillary lymph node metastasis in preoperative breast cancer core needle biopsy according to intrinsic subtypes.

Yoo SH, Park IA, Chung YR, Kim H, Lee K, Noh DY, Im SA, Han W, Moon HG, Lee KH, Ryu HS.

Hum Pathol. 2015 Feb;46(2):246-54. doi: 10.1016/j.humpath.2014.10.017. Epub 2014 Nov 12.

PMID:
25496835
6.

The superparamagnetic iron oxide is equivalent to the Tc99 radiotracer method for identifying the sentinel lymph node in breast cancer.

Rubio IT, Diaz-Botero S, Esgueva A, Rodriguez R, Cortadellas T, Cordoba O, Espinosa-Bravo M.

Eur J Surg Oncol. 2015 Jan;41(1):46-51. doi: 10.1016/j.ejso.2014.11.006. Epub 2014 Nov 15.

PMID:
25466980
7.

Association of the number of sentinel lymph nodes harvested with survival in breast cancer.

Bonneau C, Bendifallah S, Reyal F, Rossi L, Rouzier R.

Eur J Surg Oncol. 2015 Jan;41(1):52-8. doi: 10.1016/j.ejso.2014.11.004. Epub 2014 Nov 17.

PMID:
25466979
8.

Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study.

Boileau JF, Poirier B, Basik M, Holloway CM, Gaboury L, Sideris L, Meterissian S, Arnaout A, Brackstone M, McCready DR, Karp SE, Trop I, Lisbona A, Wright FC, Younan RJ, Provencher L, Patocskai E, Omeroglu A, Robidoux A.

J Clin Oncol. 2015 Jan 20;33(3):258-64. doi: 10.1200/JCO.2014.55.7827. Epub 2014 Dec 1.

PMID:
25452445
9.

Variations in the management of the axilla in screen-detected ductal carcinoma in situ: evidence from the UK NHS breast screening programme audit of screen detected DCIS.

Nicholson S, Hanby A, Clements K, Kearins O, Lawrence G, Dodwell D, Bishop H, Thompson A; Sloane Project Steering Group.

Eur J Surg Oncol. 2015 Jan;41(1):86-93. doi: 10.1016/j.ejso.2014.09.003. Epub 2014 Oct 16.

PMID:
25441934
10.

Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial.

Donker M, van Tienhoven G, Straver ME, Meijnen P, van de Velde CJ, Mansel RE, Cataliotti L, Westenberg AH, Klinkenbijl JH, Orzalesi L, Bouma WH, van der Mijle HC, Nieuwenhuijzen GA, Veltkamp SC, Slaets L, Duez NJ, de Graaf PW, van Dalen T, Marinelli A, Rijna H, Snoj M, Bundred NJ, Merkus JW, Belkacemi Y, Petignat P, Schinagl DA, Coens C, Messina CG, Bogaerts J, Rutgers EJ.

Lancet Oncol. 2014 Nov;15(12):1303-10. doi: 10.1016/S1470-2045(14)70460-7. Epub 2014 Oct 15.

11.

Intraoperative assessment of axillary lymph nodes in patients with breast cancer.

Dixon JM, Rutgers E, Hunt KK.

BMJ. 2014 Nov 25;349:g6803. doi: 10.1136/bmj.g6803. No abstract available.

PMID:
25425017
12.

Recent progress in the treatment and prevention of cancer-related lymphedema.

Shaitelman SF, Cromwell KD, Rasmussen JC, Stout NL, Armer JM, Lasinski BB, Cormier JN.

CA Cancer J Clin. 2015 Jan-Feb;65(1):55-81. doi: 10.3322/caac.21253. Epub 2014 Nov 19. Review.

PMID:
25410402
13.

The use of Ligasure vessel sealing system in axillary dissection; effect on seroma formation.

Tukenmez M, Agcaoglu O, Aksakal N, Destek S, Cabioglu N, Barbaros U, Erbil Y, Bozbora A, Dinccag A, Ozmen V, Muslumanoglu M, Igci A.

Chirurgia (Bucur). 2014 Sep-Oct;109(5):620-5.

14.

Have the American College of Surgeons Oncology Group Z0011 trial results influenced the number of lymph nodes removed during sentinel lymph node dissection?

Robinson KA, Pockaj BA, Wasif N, Kaufman K, Gray RJ.

Am J Surg. 2014 Dec;208(6):1060-4; discussion 1063-4. doi: 10.1016/j.amjsurg.2014.08.009. Epub 2014 Oct 11.

PMID:
25312842
15.

Comparison of different predictive tools of axillary status in breast cancer with micrometastatic sentinel node.

Cordero García JM, Palomar Muñoz A, García Vicente AM, Jiménez Londoño GA, León Martín AA, Pardo García R, Soriano Castrejón A.

Tumori. 2014 Jul-Aug;100(4):415-9. doi: 10.1700/1636.17898.

PMID:
25296590
16.

Impact of neoadjuvant chemotherapy on axillary nodal involvement in patients with clinically node negative triple negative breast cancer.

Connor CS, Kimler BF, Mammen JM, McGinness MK, Wagner JL, Alsop SM, Ward C, Fabian CJ, Khan QJ, Sharma P.

J Surg Oncol. 2015 Feb;111(2):198-202. doi: 10.1002/jso.23790. Epub 2014 Sep 29.

PMID:
25266871
17.

Extranodal extension on sentinel lymph node dissection: why should we treat it differently?

Choi AH, Surrusco M, Rodriguez S, Bahjri K, Solomon N, Garberoglio C, Lum S, Senthil M.

Am Surg. 2014 Oct;80(10):932-5.

PMID:
25264632
18.

[Prospect and guideline update of sentinel lymph node biopsy for patients with early-stage breast carcinoma].

Zhou MQ, Chen HL, Hu Y, Deng YC, Zheng S.

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2014 Jul;43(4):381-7. Review. Chinese.

PMID:
25187451
19.

Long-term follow-up of 5262 breast cancer patients with negative sentinel node and no axillary dissection confirms low rate of axillary disease.

Galimberti V, Manika A, Maisonneuve P, Corso G, Salazar Moltrasio L, Intra M, Gentilini O, Veronesi P, Pagani G, Rossi E, Bottiglieri L, Viale G, Rotmensz N, De Cicco C, Grana CM, Sangalli C, Luini A.

Eur J Surg Oncol. 2014 Oct;40(10):1203-8. doi: 10.1016/j.ejso.2014.07.041. Epub 2014 Aug 20.

PMID:
25186914
20.

Impact of sentinel node tumor burden on outcome of invasive breast cancer patients.

Meattini I, Desideri I, Saieva C, Francolini G, Scotti V, Bonomo P, Greto D, Mangoni M, Nori J, Orzalesi L, Fambrini M, Bianchi S, Livi L.

Eur J Surg Oncol. 2014 Oct;40(10):1195-202. doi: 10.1016/j.ejso.2014.08.471. Epub 2014 Aug 20.

PMID:
25179162
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk